1. Home
  2. BPMC vs WAY Comparison

BPMC vs WAY Comparison

Compare BPMC & WAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BPMC
  • WAY
  • Stock Information
  • Founded
  • BPMC 2008
  • WAY 1999
  • Country
  • BPMC United States
  • WAY United States
  • Employees
  • BPMC N/A
  • WAY N/A
  • Industry
  • BPMC Biotechnology: Pharmaceutical Preparations
  • WAY
  • Sector
  • BPMC Health Care
  • WAY
  • Exchange
  • BPMC Nasdaq
  • WAY Nasdaq
  • Market Cap
  • BPMC 5.8B
  • WAY 6.1B
  • IPO Year
  • BPMC 2015
  • WAY 2024
  • Fundamental
  • Price
  • BPMC $88.51
  • WAY $37.36
  • Analyst Decision
  • BPMC Buy
  • WAY Strong Buy
  • Analyst Count
  • BPMC 22
  • WAY 12
  • Target Price
  • BPMC $124.29
  • WAY $41.73
  • AVG Volume (30 Days)
  • BPMC 958.8K
  • WAY 2.1M
  • Earning Date
  • BPMC 05-01-2025
  • WAY 05-10-2025
  • Dividend Yield
  • BPMC N/A
  • WAY N/A
  • EPS Growth
  • BPMC N/A
  • WAY N/A
  • EPS
  • BPMC N/A
  • WAY N/A
  • Revenue
  • BPMC $508,824,000.00
  • WAY $943,549,000.00
  • Revenue This Year
  • BPMC $45.43
  • WAY $8.21
  • Revenue Next Year
  • BPMC $32.80
  • WAY $9.79
  • P/E Ratio
  • BPMC N/A
  • WAY N/A
  • Revenue Growth
  • BPMC 104.04
  • WAY 19.28
  • 52 Week Low
  • BPMC $80.68
  • WAY $20.26
  • 52 Week High
  • BPMC $121.90
  • WAY $48.11
  • Technical
  • Relative Strength Index (RSI)
  • BPMC 43.04
  • WAY N/A
  • Support Level
  • BPMC $86.99
  • WAY N/A
  • Resistance Level
  • BPMC $93.04
  • WAY N/A
  • Average True Range (ATR)
  • BPMC 3.36
  • WAY 0.00
  • MACD
  • BPMC 0.32
  • WAY 0.00
  • Stochastic Oscillator
  • BPMC 29.62
  • WAY 0.00

About BPMC Blueprint Medicines Corporation

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.

About WAY Waystar Holding Corp. Common Stock

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

Share on Social Networks: